Menu

The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.

Just Before Departing, Biden Admin Announces Next 15 Drugs for Medicare Negotiations Amid IRA Uncertainty and 340B Questions

January 22, 2025 Bella Czajkowski and William Newton, National Correspondent 340B Report Views

The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Bella Czajkowski and William Newton

CPS

Federal 340B Lobbying Activity Held Steady in Q4 of 2024, Filings Show